ArTS Archivio della ricerca di Trieste

GUARNIERI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.102
AS - Asia 5.936
EU - Europa 5.719
SA - Sud America 574
AF - Africa 162
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 20
Totale 27.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.932
SG - Singapore 2.287
CN - Cina 1.565
SE - Svezia 951
UA - Ucraina 839
IT - Italia 830
PL - Polonia 574
VN - Vietnam 563
HK - Hong Kong 531
DE - Germania 523
BR - Brasile 429
FI - Finlandia 408
FR - Francia 359
KR - Corea 317
GB - Regno Unito 302
RU - Federazione Russa 248
TR - Turchia 235
BG - Bulgaria 146
IE - Irlanda 144
NL - Olanda 123
IN - India 119
CA - Canada 103
CH - Svizzera 71
JP - Giappone 62
AR - Argentina 59
MA - Marocco 53
BE - Belgio 52
MX - Messico 44
BD - Bangladesh 34
SN - Senegal 31
ZA - Sudafrica 26
ES - Italia 23
AU - Australia 21
IQ - Iraq 21
SA - Arabia Saudita 21
TH - Thailandia 21
CO - Colombia 20
RS - Serbia 20
PH - Filippine 18
PK - Pakistan 18
EC - Ecuador 17
VE - Venezuela 17
ID - Indonesia 16
AE - Emirati Arabi Uniti 14
LT - Lituania 14
AT - Austria 13
EU - Europa 13
EG - Egitto 12
JO - Giordania 12
IL - Israele 11
RO - Romania 11
CZ - Repubblica Ceca 10
DK - Danimarca 10
TW - Taiwan 10
AZ - Azerbaigian 9
KE - Kenya 9
UZ - Uzbekistan 9
MY - Malesia 8
PE - Perù 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CL - Cile 7
OM - Oman 6
PT - Portogallo 6
PY - Paraguay 6
JM - Giamaica 5
NG - Nigeria 5
SI - Slovenia 5
TN - Tunisia 5
UY - Uruguay 5
DZ - Algeria 4
IR - Iran 4
KZ - Kazakistan 4
MK - Macedonia 4
MP - Marianne Settentrionali, isole 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
EE - Estonia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MT - Malta 3
PR - Porto Rico 3
AO - Angola 2
BF - Burkina Faso 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
Totale 27.509
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.676
Fairfield 1.526
Singapore 1.387
Ashburn 1.347
Ann Arbor 1.338
Houston 1.302
Chandler 942
Jacksonville 747
Wilmington 709
Seattle 628
San Jose 596
Hong Kong 517
Cambridge 512
Warsaw 429
Hefei 399
Beijing 342
Seoul 305
Princeton 272
Boardman 262
Trieste 189
Izmir 187
Chicago 182
Los Angeles 167
Ho Chi Minh City 163
Hanoi 148
Dublin 144
Columbus 143
Sofia 143
Lauterbourg 131
Zgierz 128
Helsinki 127
Santa Clara 112
Dearborn 110
The Dalles 109
Moscow 101
Frankfurt am Main 99
Milan 93
Buffalo 88
Dallas 79
San Diego 77
Düsseldorf 73
Munich 71
Bern 57
Grafing 57
New York 55
Brussels 49
São Paulo 48
London 47
Casablanca 46
Des Moines 46
Tokyo 45
Verona 44
Atlanta 34
Montreal 33
Phoenix 33
Turku 33
Falls Church 32
Da Nang 31
Dakar 31
Bremen 30
Guangzhou 30
Nanjing 29
Chennai 28
Kunming 27
Shanghai 27
Shenyang 27
Washington 27
Orem 26
Tianjin 26
Ottawa 25
Mestre 24
Auburn Hills 23
Denver 23
Norwalk 22
Jinan 21
Brooklyn 20
Redondo Beach 20
Rio de Janeiro 20
Toronto 20
Belgrade 19
Council Bluffs 18
Haiphong 18
Stockholm 18
Boston 17
San Francisco 17
Nuremberg 16
Pune 16
Bangkok 15
Johannesburg 15
Amsterdam 14
Ankara 14
Hải Dương 14
Venice 14
Fremont 13
Zhengzhou 13
Chengdu 12
Istanbul 12
Nanchang 12
Ninh Bình 12
Riyadh 12
Totale 19.627
Salva come PNG Salva come JPEG
Nome #
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 508
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 399
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 328
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 315
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 309
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 302
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 301
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 286
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion. 285
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 283
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 283
Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. 282
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 279
D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up. 276
Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment 269
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 267
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 258
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 255
Amino acid and protein therapy in chronic renal failure. 254
Nutrition in Renal Disease 253
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 253
Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. 250
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 248
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 246
Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients. 244
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 244
Whey protein ingestion enhances postprandial anabolism during short-term bed rest in young men. 244
Metabolic response to injury and sepsis: changes in protein metabolism. 230
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. 225
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3 224
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile 220
Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis. 220
Effects of growth hormone administration on skeletal muscle glutamine metabolism in severely traumatized patients: preliminary report. 219
Mechanisms of malnutrition in uremia. 211
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 211
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 210
Carnitine metabolism in uremia 206
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 205
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. 204
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 203
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 200
Slower activation of insulin action in hypertension associated with obesity. 197
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 196
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 196
Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity. 191
Effects of L-carnitine supplementation in the dialysate on serum lipoprotein composition of hemodialysis patients. 190
Modulation of protein kinetics in chronic renal failure. 190
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. 190
MMP-9 microsatellite polymorphism and multiple sclerosis. 187
Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. 187
Sensitivity of whole body protein synthesis to amino acid administration during short-term bed rest. 186
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 185
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 185
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 184
Antibiotics and renal tubular damage in cirrhosis. 182
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. 181
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo 177
Evaluation of dietary compliance in patients with chronic renal failure on conservative treatment: comparison of methods to assess dietary intake 173
Molecular regulation of protein catabolism in trauma patients. 172
Potential applications of small interferring RNA in the cardiovascular field 169
Charactherization of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 166
The Kidney 165
Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. 164
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 163
Rheological properties of aqueous Pluronic-alginate systems containing liposomes 163
Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. 161
The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index – Results from the North-East Italy MoMa Population Study 161
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 161
Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis 158
Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction 157
null 155
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 155
High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease 155
Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. 154
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 154
Nutritional and metabolic effects of ten years of protein-restricted diet in patients with early renal failure 153
Effects of erythropoietin administration on nutritional state and erythrocyte metabolism in maintenance hemodialysis patients. 152
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 152
null 152
Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. 151
Slower activation of insulin action in upper body obesity. 149
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 149
Simple methods for nutritional assessment in hemodialyzed patients 148
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 146
Metabolic syndrome and chronic kidney disease. 144
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 144
Advances in carnitine in chronic uremia 142
Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases 142
Muscle cathepsin D activity, and RNA, DNA and protein content in maintenance hemodialysis patients. 139
Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. 139
Calorie restriction accelerates the catabolism of lean body mass during 2 wk of bed rest. 136
Clinical Nutrition 135
Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats 135
null 134
Circulating Fatty Acids are Associated with Acyl- and Desacyl-Ghrelin Balance in Humans 134
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 133
null 132
Potential Application Of Proteasome Inhibitor Bortezomib For Treatment Of Hepatocellular Carcinoma 131
Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease 131
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile 129
Totale 20.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021628 0 0 0 0 0 0 0 0 0 284 122 222
2021/20221.780 71 120 60 186 64 190 69 52 187 190 181 410
2022/20232.607 233 336 201 393 238 476 7 223 316 20 135 29
2023/20241.354 151 104 93 83 141 119 253 168 12 35 109 86
2024/20253.022 46 80 212 286 313 299 215 155 399 375 285 357
2025/20266.850 727 402 535 633 703 766 1.229 221 788 846 0 0
Totale 28.068